Literature DB >> 19422349

Changes in pediatric renal transplantation after implementation of the revised deceased donor kidney allocation policy.

S Agarwal1, N Oak, J Siddique, R C Harland, E D Abbo.   

Abstract

In October 2005, the United Network for Organ Sharing (UNOS) implemented a revised allocation policy requiring that renal allografts from young deceased donors (DDs) (<35 years old) be offered preferentially to pediatric patients (<18 years old). In this study, we compare the pre- and postpolicy quarterly pediatric transplant statistics from 2000 to 2008. The mean number of pediatric renal transplants with young DDs increased after policy implementation from 62.8 to 133 per quarter (p < 0.001), reflecting a change in the proportion of all transplants from young DDs during the study period from 0.33 to 0.63 (p < 0.001). The mean number of pediatric renal transplants from old DDs (> or =35 years old) decreased from 22.4 to 2.6 per quarter (p < 0.001). The proportion of all pediatric renal transplants from living donors decreased from 0.55 to 0.35 (p < 0.001). The proportion from young DDs with five or six mismatched human leukocyte antigen (HLA) loci increased from 0.16 to 0.36 (p < 0.001) while those with 0 to 4 HLA mismatches increased from 0.18 to 0.27 (p < 0.001). Revision of UNOS policy has increased the number of pediatric renal transplants with allografts from young DDs, while increasing HLA-mismatched allografts and decreasing the number from living donors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422349     DOI: 10.1111/j.1600-6143.2009.02608.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  21 in total

1.  Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients.

Authors:  Jessica M Ruck; Annette M Jackson; Allan B Massie; Dorry L Segev; Niraj Desai; Jacqueline Garonzik-Wang
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

2.  Renal allograft loss due to renal vascular thrombosis in the US pediatric renal transplantation.

Authors:  Chia-Shi Wang; Larry A Greenbaum; Rachel E Patzer; Rouba Garro; Barry Warshaw; Roshan P George; Pamela D Winterberg; Kavita Patel; Julien Hogan
Journal:  Pediatr Nephrol       Date:  2019-05-26       Impact factor: 3.714

3.  The consequences of chronic kidney disease mislabeling in living kidney donors.

Authors:  Colin R Lenihan; Jane C Tan
Journal:  Mayo Clin Proc       Date:  2014-05-24       Impact factor: 7.616

4.  National trends over 25 years in pediatric kidney transplant outcomes.

Authors:  Kyle J Van Arendonk; Brian J Boyarsky; Babak J Orandi; Nathan T James; Jodi M Smith; Paul M Colombani; Dorry L Segev
Journal:  Pediatrics       Date:  2014-03-10       Impact factor: 7.124

5.  Order of donor type in pediatric kidney transplant recipients requiring retransplantation.

Authors:  Kyle J Van Arendonk; Nathan T James; Babak J Orandi; Jacqueline M Garonzik-Wang; Jodi M Smith; Paul M Colombani; Dorry L Segev
Journal:  Transplantation       Date:  2013-09-15       Impact factor: 4.939

Review 6.  Delayed graft function and its management in children.

Authors:  Ryszard Grenda
Journal:  Pediatr Nephrol       Date:  2016-10-24       Impact factor: 3.714

7.  Geographic determinants of access to pediatric deceased donor kidney transplantation.

Authors:  Peter P Reese; Hojun Hwang; Vishnu Potluri; Peter L Abt; Justine Shults; Sandra Amaral
Journal:  J Am Soc Nephrol       Date:  2014-01-16       Impact factor: 10.121

Review 8.  Long-Term Outcomes of Kidney Transplantation in Children.

Authors:  Pamela D Winterberg; Rouba Garro
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

9.  Vascular access for chronic hemodialysis in children: arteriovenous fistula or central venous catheter?

Authors:  Aicha Merouani; Michel Lallier; Julie Paquet; Johanne Gagnon; Anne Laure Lapeyraque
Journal:  Pediatr Nephrol       Date:  2014-08-08       Impact factor: 3.714

10.  Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease.

Authors:  Sandra Amaral; Blayne A Sayed; Nancy Kutner; Rachel E Patzer
Journal:  Kidney Int       Date:  2016-09-18       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.